Sorrento Therapeutics, Inc.
SRNE
SRNE was delisted on the 22nd of February, 2023.
68 hedge funds and large institutions have $69.3M invested in Sorrento Therapeutics, Inc. in 2016 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 27 increasing their positions, 11 reducing their positions, and 25 closing their positions.
145% more repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 11
19% less funds holding
Funds holding: 84 → 68 (-16)
39% less capital invested
Capital invested by funds: $114M → $69.3M (-$44.9M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
64% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 25
76% less call options, than puts
Call options by funds: $30K | Put options by funds: $123K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TC
TFS Capital
West Chester,
Pennsylvania
|
+$1.04M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$844K |
| 3 |
SM
Sabby Management
Miami Beach,
Florida
|
+$464K |
| 4 |
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System
Harrisburg,
Pennsylvania
|
+$425K |
| 5 |
TCIM
TIAA CREF Investment Management
New York
|
+$375K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$1.77M |
| 2 |
AQR Capital Management
Greenwich,
Connecticut
|
-$1.08M |
| 3 |
NI
Numeric Investors
Boston,
Massachusetts
|
-$899K |
| 4 |
TI
Trexquant Investment
Stamford,
Connecticut
|
-$592K |
| 5 |
LCM
Landscape Capital Management
Englewood,
New Jersey
|
-$476K |
SRNE Hedge Fund Activity: Q1 2016 in Review
68 of the 3,767 institutional investors tracked by Wall St. Rank reported a position in Sorrento Therapeutics, Inc. (SRNE) for Q1 2016, worth a combined $69.3M — down 39% from $114M a quarter earlier.
Sellers outnumbered buyers: 25 funds closed out of SRNE and 9 opened new positions — a net loss of 16 holders — while 11 trimmed existing stakes and 27 added.
The largest buyer was TFS Capital, adding an estimated $1.04M. The largest seller was Millennium Management, cutting an estimated $1.77M.
- 68 institutional investors held Sorrento Therapeutics, Inc. (SRNE) as of Q1 2016, down from 84 in Q4 2015.
- Funds reported $69.3M of Sorrento Therapeutics, Inc. stock for Q1 2016, down 39% quarter-over-quarter.
- 9 funds opened new Sorrento Therapeutics, Inc. positions in Q1 2016 and 25 closed out, a net change of -16 holders.
- The largest Sorrento Therapeutics, Inc. buyer in Q1 2016 was TFS Capital, an estimated $1.04M added.
- The largest Sorrento Therapeutics, Inc. seller in Q1 2016 was Millennium Management, an estimated $1.77M sold.
Based on aggregated 13F filings for Q1 2016.